Malaria poses a significant threat to public health, disproportionately affecting the most vulnerable populations. EVI strengthens the fight

World Tuberculosis Day serves as a poignant reminder to raise awareness about tuberculosis (TB). Despite the efforts and promising...

The TBVI Governance Board is pleased to announce the appointment of Dr. Ole F. Olesen as their new Executive Director.

The blood-stage malaria vaccine BK-SE36/CpG was found to be safe and induced anti-SE36 antibodies in all cohorts.

Across the globe, women and girls are making remarkable contributions to scientific research, innovation, and discovery.

Untreated NTDs presently affect 1.7 billion individuals globally. The most severely impacted are the impoverished segments of society.

Passionate about making a significant impact in the fields of infectious diseases and AMR? Join DRAIGON.

The ambitious project mission is to develop a novel diagnostic tool to tackle antimicrobial resistance (AMR) through the integration of...

In a significant development, Professor Sam McConkey, the Head of the Department of International Health and Tropical Medicine at RCSI...

AMR poses a significant global threat, with nearly 5 million deaths associated with bacterial AMR in 2019. EVI contributes to the fight.

EVI actively participates in various EDCTP projects such as ShigaPlexIM, PREV_PKDL, MMVC, MIMVaC-Africa, and MVPE-CC, fellowships & more.

In the heart of Wuxi, China, the forum explored the forefront of vaccine R&D with discussions on revolutionary mRNA-based vaccines and more.

Vaccine hesitancy among healthcare workers in Europe became a growing concern: doubts about effectiveness and safety, misbeliefs.

A new feasibility study that looked at a sustainable economic model for vaccine R&D infrastructure demonstrates that they could have a...

EU-funded CAPTIVATE project has the mission to create a next-generation malaria vaccine.

New clinical trial in Burkina Faso assessed the safety and immunogenicity of the BK-SE36/CpG malaria vaccine in healthy adults and children.

October 2, 2023 In a significant stride toward combatting malaria and Neglected Tropical Diseases (NTDs), the Global Health Innovative...

July 2023 The TRANSAVC2 project concluded with its final meeting, which took place in a hybrid format on April 19-20, 2023, in Brussels....

26 June 2023 On 29-31 May 2023, European Vaccine Initiative (EVI) in collaboration with Uganda Virus Research Institute-International...

Over the next 4 years, the UltiMalVax consortium will work to develop the ultimate vaccine for malaria elimination. This would be a...

Over the next 5 years, the NOSEVAC consortium will work intensively to create nasal vaccines targeting S. pneumoniae and B. pertussis...

07 June 2023 A Collaborative Vision: A new article highlighting the efforts to establish a robust vaccine research and development (R&D)...

27 April 2023 Malaria remains a major health challenge, particularly in sub-Saharan Africa, where children under five face the greatest...

On April 25th, we celebrate World Malaria Day and reflect on the progress that has been made in the fight against malaria. This year's theme